Protagenic Therapeutics, Inc.\new
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $6.9M | — |
| FY2023 | — | $3.7M | — |
| FY2024 | — | $-1.8M | $1.6K |
| FY2025 | — | $-5.0M | $14.5K |
| FY2026 | — | $2.6M | $1.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $6.9M | — |
| FY2023 | — | $3.7M | — |
| FY2024 | — | $-1.8M | $1.6K |
| FY2025 | — | $-5.0M | $14.5K |
| FY2026 | — | $2.6M | $1.5M |